跳至主要内容
临床试验/NCT04979767
NCT04979767Unknown不适用

Function of Circulating Exosomes in Sepsis-induced Immunosuppression

University of Kansas Medical Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年4月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
1
主要终点
28-day mortality

研究概览

简要总结

This is a single-center prospective bio-specimen analysis and observational study aiming to define immune pathways disrupted in bacterial sepsis and to identify clinically useful biomarkers of immune status.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 50 years with ≥ 2 chronic comorbidities
  • Highly suspected bacterial infection based on clinical or radiologic evidence
  • ≥ 2 systemic inflammatory response syndrome (SIRS) criteria
  • Actual/anticipated admission to intensive care unit (ICU)
  • Anticipated length of hospital stay ≥ 5 days

排除标准

  • Pregnancy
  • Underlying immunosuppression (solid organ transplant, hematopoietic stem cell transplant, neutropenia, HIV infection, long-term corticosteroid use (≥ 20 mg prednisone equivalents for ≥ 14 days), immunosuppressants, radiation, chemotherapy, immune-modifying biologics, viral hepatitis, or systemic autoimmune diseases)
  • Current immunotherapy use
  • Confirmed COVID-19 infection

结局指标

主要结局

28-day mortality

时间窗: From enrollment to 28 days

All-cause mortality

次要结局

  • Duration of infection(From enrollment until resolution of SIRS, up to 90 days)
  • Hospital mortality(From enrollment until hospital discharge, up to 90 days)
  • 90-day mortality(From enrollment to 90 days)
  • Length of stay(From enrollment until hospital discharge, up to 90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nicholas Britt

Assistant Professor

University of Kansas Medical Center

研究点 (1)

Loading locations...

相似试验